EIM Group
http://www.eimgroup.com/jahia/page2.htmlEIM Group is a fund of fund that focuses on identifying, screening, and analyzing the best fund managers in different markets and investment styles.
View Older Stories View More Recent Stories
-
Preview: Visa (V) Looks to Increased Spending, International Growth for a Q3 Beat (DFS, AXP, MA, More...)
-
Unusual 11 Mid-Day Movers 07/28: APL, SIMG, HGRD, FCEL, EHTH, AFFX Higher; ONP, DJSP, SBX, MSO, CIIC Lower
-
Morning Movers 7/28: HGRD, APL, SIMG, AHD, EHTH, WYN, RCKY Higher; ONP, CIIC, FORM, HTCH, SBX, STSA, ALTH, EK Lower
-
BP (BP) Q2 Earnings Preview: CEO, Cash Flows, Future Growth and Liability All In Question
-
Dendreon (DNDN) Higher After Positive PROVENGE Survey Results
-
Eisai Inc. and Pfizer (PFE) Receive U.S. FDA Approval for Higher-Dose Aricept
-
Canaccord Genuity Q2 Preview on Energy & Power Technologies: Rubicon Technology (RBCN) Remains 'Best Idea'
-
Highlights From AAPL's Q3 Conference Call: Highest Quarterly Revenue Ever - Six Billion Increase Over Prior June Qtr
-
Apple (AAPL) Does It Again With Blow-Out Q3 Results; Mac Sales Jump 33%, iPhone Up 61%
-
Goldman Sachs (GS) Q2 Earnings Preview: SEC Settlment Positive, But Won't Add to Q2
-
Analyst Round-Up GE: Goldman Calls Results a 'High Quality Beat', Deutsche Notes Strength in Industrial Margins
-
BofA, Oppenheimer, Buckingham Upgrade Goldman (GS) Shares Following SEC Settlement
-
Notable Analyst Rating Changes 07/16: GS, JPM, ARNA, ADM Upgraded; VVUS, BP, RBA, OREX Downgraded
-
Can Citigroup (C) Continue the Momentum for Q2? (JPM, WFC, BAC)
-
Needham & Company Reiterates a 'Buy' Rating Dendreon (DNDN); 2Q10 Earnings Preview
-
Anadarko (APC) to Withhold Reimbursement from BP; Will Work in 'Good Faith' to Achieve a Satisfactory Resolution
-
Notable 52-Week High's and Low's of the Day 07/07: AMT, VTIV High; VZ, FCN, XNPT, AFFX, BEAT Low
-
Oppenheimer Upgrades EMC (EMC) to Outperform
-
Notable 52-Week High's and Low's of the Day 07/06: DLTR, CPNO, VTIV High; DELL, AUXl, CKEC Low
-
Baird Defends Dendreon (DNDN) After CMS Analysis News, Says Worst Case Not Supported By Facts
-
OctoPlus N.V. Signs DevelopmentAgreement with Novartis; To Use Proprietary Compound PolyActive
-
Tenet Healthcare (THC) and CIGNA (CI) Sign New Multi-Year Agreement
-
Oppenheimer Downgrades Amerisafe (AMSF) to Market Perform
-
Unusual 11 Mid-Day Movers 06/24: ADG, MIPI, EDAP, VVTV, SBP, CDZI Higher; MAG, AMPL, CYS, PRKR, BID Lower
-
Oppenheimer Upgrades Monster Worldwide (MWW) to Outperform
-
Guggenheim Starts Homebuilding Stocks: TOL, MHO at Buy, KBH, MDC, RYL, DHI, NVR at Sell
-
Notable Analyst Rating Changes 06/14: CRNT, JBLU, AMLN, HIG Upgraded; AKAM, ISRG, DO, ARCL Downgraded
-
Cablevision Systems (CVC) Announces $1.37B Acquisition of Bresnan Com
-
Lionsgate (LGF) Issues Letter to Shareholders
-
CVS/Walgreen Fight Heats Up and Investors Lose
-
CVS Caremark (CVS) Announces Plan to Remove Walgreens (WAG) from PBM Pharmacy Network
-
Dendreon (DNDN) Sell-Off a Great Entry Point - Analyst
-
CVS's Pain May Be Rivals Gain (ESRX, MHS)
-
CVS Caremark (CVS) Lower After Walgreen (WAG) Walks
-
Minor Success Seen In Containing BP Oil Spill
-
U.S. Launches Civil, Criminal Probe of BP Oil Spill
-
Oppenheimer Upgrades BP plc (BP) to Outperform
-
Oppenheimer Upgraded Citigroup (C) to Outperform
-
Sequenom (SQNM): Bullish on the technology and Sequenom's prospects for commercializing T-21 in 2011 - Barclays
-
Oppenheimer Initiates Coverage on Globe Specialty Metals (GSM) with an Outperform
-
Oppenheimer Upgrades Office Depot (ODP) to Perform
-
Oppenheimer Downgrades Anadarko Petroleum (APC) to Perform
-
Morning Movers 4/29: ATSI, PRAN, RAS, IRBT, PALM, GTI Higher; PCBC, CASB, FIRE, HAR, OPWV, FICO Lower
-
Notable Analyst Rating Changes 04/23: YGE, WDC, CPHD, HSY Upgraded; VZ, DO, ASBC, NOK Downgraded
-
Morning Movers 4/23: IBNK, MBTF, CACB, STSA, ACTG, WAL, SPF Higher; ACUR, PEGA, HRZ, PXLW, OPLK, AVID Lower
-
Highlights From AAPL's Q2 Conference Call: Reported Best Non-Holiday Quarter of Revenue & Earnings Ever
-
Oppenheimer Lifts Their Price Target on General Electric (GE) to $23
-
Oppenheimer Maintains Positive Stance of General Electric (GE) Following Results
-
General Electric (GE) Q1 EPS Beat, But Sales Fall Short; Loan Loss Provisions Down Sharply
-
Morning Movers 4/14: DCAI, AEN, ABK, KLIC, HOTT Higher; RPC, CPRX, MIPI, SSN Lower

